Ernexa Therapeutics Inc. Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
Ernexa Therapeutics Inc. (ERNA) reported Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation of 42.00 thousand shares for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation · last filed 2021-03-11
- Ernexa Therapeutics Inc. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2019-06-30 was 4.00K shares.
- Ernexa Therapeutics Inc. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2019-03-31 was 3.00K shares.
- Ernexa Therapeutics Inc. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2018-12-31 was 3.00K shares.
- Ernexa Therapeutics Inc. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2020 was 42.00K shares, a 61.54% increase from fiscal 2019.
- Ernexa Therapeutics Inc. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2019 was 26.00K shares, a 188.89% increase from fiscal 2018.
- Ernexa Therapeutics Inc. share-based payment arrangement, shares withheld for tax withholding obligation for fiscal 2018 was 9.00K shares.
| Period end | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2020-12-31 | 42.00K shares 10-K · filed 2021-03-11 | |||
| 2019-12-31 | 26.00K shares 10-K · filed 2021-03-11 | |||
| 2019-06-30 | 4.00K shares 10-Q · filed 2019-08-12 | 7.00K shares 10-Q · filed 2019-08-12 | 10.00K shares derived: sum of 3 quarters · filed 2020-03-19 | |
| 2019-03-31 | 3.00K shares 10-Q · filed 2019-05-14 | 6.00K shares derived: sum of 2 quarters · filed 2020-03-19 | ||
| 2018-12-31 | 3.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | 9.00K shares 10-K · filed 2020-03-19 | ||
| 2018-09-30 | 6.00K shares 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |